SFMBT1 facilitates colon cancer cell metastasis and drug resistance combined with HMG20A

In colorectal cancer (CRC), the development of reagents that increase sensitivity to chemotherapeutic agents could prevent drug resistance and improve patient survival. Scm-like with four malignant brain tumor domains 1 (SFMBT1) is up-regulated in CRC tumor tissues and cells and may be associated wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Ruijun, Yu, Dingye, Hu, Jiajia, Yang, Xiao, Wang, Chenxing, Zhang, Luyang, Xue, Pei, Sun, Jing, Zhang, Xiaoping, Cai, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110378/
https://www.ncbi.nlm.nih.gov/pubmed/35577773
http://dx.doi.org/10.1038/s41420-022-01057-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110378/
https://www.ncbi.nlm.nih.gov/pubmed/35577773
http://dx.doi.org/10.1038/s41420-022-01057-7

Ejemplares similares